These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2302 related articles for article (PubMed ID: 8292896)
1. Changes in plasma 5-S-cysteinyldopa concentration in B16 melanoma-bearing mice treated with interferon-beta or dacarbazine. Hasegawa K; Inoue S; Wakamatsu K; Ito S; Fujita K; Ishihara K Melanoma Res; 1993 Oct; 3(5):377-80. PubMed ID: 8292896 [TBL] [Abstract][Full Text] [Related]
2. Melanin-related metabolites in urine of B16 melanoma-bearing mice. Wakamatsu K; Ito S; Fujita K Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020 [TBL] [Abstract][Full Text] [Related]
3. The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma. Kiyohara E; Tamai K; Katayama I; Kaneda Y Gene Ther; 2012 Jul; 19(7):734-41. PubMed ID: 21900962 [TBL] [Abstract][Full Text] [Related]
4. Plasma 5-S-cysteinyldopa correlates with tumor size in melanoma-bearing mice. Hu F; Woodward WR; Peterson LL J Invest Dermatol; 1988 Feb; 90(2):149-51. PubMed ID: 3123557 [TBL] [Abstract][Full Text] [Related]
5. Research on the anti-tumour effect of steroid lactam alkylator (NSC-294859) in comparison with conventional chemotherapeutics in malignant melanoma. Trafalis DT; Camoutsis C; Papageorgiou A Melanoma Res; 2005 Aug; 15(4):273-81. PubMed ID: 16034305 [TBL] [Abstract][Full Text] [Related]
6. In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine. Sadhu SS; Wang S; Averineni RK; Seefeldt T; Yang Y; Guan X Melanoma Res; 2016 Dec; 26(6):572-579. PubMed ID: 27540834 [TBL] [Abstract][Full Text] [Related]
7. B16 and cloudman S91 mouse melanoma cells susceptibility to apoptosis after dacarbazine treatment. Olszewska-Słonina DM; Styczyńisk J; Drewa TA; Olszewski KJ; Czajkowski R Acta Pol Pharm; 2005; 62(6):473-83. PubMed ID: 16583988 [TBL] [Abstract][Full Text] [Related]
8. High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma. Pica F; Fraschetti M; Matteucci C; Tuthill C; Rasi G Anticancer Res; 1998; 18(5A):3571-8. PubMed ID: 9858941 [TBL] [Abstract][Full Text] [Related]
9. Ethanol extract of Ilex hainanensis Merr. exhibits anti-melanoma activity by induction of G Zhang YQ; Yang H; Sun WD; Wang J; Zhang BY; Shen YJ; Yin MQ; Liu YX; Liu C; Sun Y Chin J Integr Med; 2018 Jan; 24(1):47-55. PubMed ID: 28741062 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy. Wimmer I; Meyer JC; Seifert B; Dummer R; Flace A; Burg G Cancer Res; 1997 Nov; 57(22):5073-6. PubMed ID: 9371505 [TBL] [Abstract][Full Text] [Related]
11. Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth. Hervieu A; Rébé C; Végran F; Chalmin F; Bruchard M; Vabres P; Apetoh L; Ghiringhelli F; Mignot G J Invest Dermatol; 2013 Feb; 133(2):499-508. PubMed ID: 22951720 [TBL] [Abstract][Full Text] [Related]
12. Treatment of malignant melanoma with dacarbazin (DTIC-DOME) with special reference to urinary excretion of 5-S-cysteinyldopa. Jönsson PE; Agrup G; Arnbjörnsson E; Hafström L; Rorsman H Cancer; 1980 Jan; 45(2):245-8. PubMed ID: 6153150 [TBL] [Abstract][Full Text] [Related]
13. Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis. Lum CT; Huo L; Sun RW; Li M; Kung HF; Che CM; Lin MC Acta Oncol; 2011 Jun; 50(5):719-26. PubMed ID: 21110776 [TBL] [Abstract][Full Text] [Related]
14. Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma. Szende B; Horváth A; Bökönyi G; Kéri G Br J Cancer; 2003 Jan; 88(1):132-6. PubMed ID: 12556972 [TBL] [Abstract][Full Text] [Related]
15. Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients. Chabot GG; Flaherty LE; Valdivieso M; Baker LH Cancer Chemother Pharmacol; 1990; 27(2):157-60. PubMed ID: 2249333 [TBL] [Abstract][Full Text] [Related]
16. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model. Wack C; Becker JC; Bröcker EB; Lutz WK; Fischer WH Melanoma Res; 2001 Jun; 11(3):247-53. PubMed ID: 11468513 [TBL] [Abstract][Full Text] [Related]
17. PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo. Jin JL; Gong J; Yin TJ; Lu YJ; Xia JJ; Xie YY; Di Y; He L; Guo JL; Sun J; Noteborn MH; Qu S Eur J Pharmacol; 2011 Mar; 654(1):17-25. PubMed ID: 21184754 [TBL] [Abstract][Full Text] [Related]
18. Production, circulation, and excretion of melanin-related metabolites in B16 melanoma-bearing mice. Wakamatsu K; Ito S; Fujita K Acta Derm Venereol; 1990; 70(5):367-72. PubMed ID: 1980967 [TBL] [Abstract][Full Text] [Related]
19. Orally administered rapamycin, dacarbazine or both for treatment of human melanoma evaluated in severe combined immunodeficiency mice. Thallinger C; Skorjanec S; Soleiman A; Tzaneva S; Griss J; Rous W; Poeppl W; Weinlich G; Karimian-Teherani D; Joukhadar C Pharmacology; 2008; 82(3):233-8. PubMed ID: 18810248 [TBL] [Abstract][Full Text] [Related]
20. [Construction of an angiostatin eukaryotic expression vector and characterization of its inhibitory efficiency in B16 melanoma bearing mice]. Wang JS; Sun DJ; Guo LH; Lin GW; Fei J Shi Yan Sheng Wu Xue Bao; 2002 Dec; 35(4):303-6. PubMed ID: 15346988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]